Cancer development is regarded as the result of constant mutual interactions between tumor cells and their surrounding environments. Mounting evidence indicates that nerves constitute an essential non-neoplastic cell type in central and peripheral tumors. The crosstalk between them implies that both counterparts secrete factors that favor their rapid growth, making the cancer-nerve interaction a reciprocally beneficial process. [1] It is a fact that a tumor can support the formation of the new nerve inside its environment via secreting neuronal growth factors and axon guidance molecules like NGF, BDNF, or FGF. [2] Analogous to the key role of the nervous system on tissue, the effect of neurogenesis will control malignant tumor initiation, growth, and metastasis via paracrine signaling (e.g., dopamine, serotonin, and tachykinins) and direct electrochemical communication (e.g., Ca 2+ , Na + , H + ). [3] Quite evidently, a precise understanding of how this reciprocal system operates will provide new insights for therapeutic intervention against cancer, different from conventional cancer immunity or a systemic tumor environment. [4] In 2019, "cancer neuroscience" was formally proposed by neuroscience and cancer biology members to encourage multidisciplinary collaboration to study nervous system-cancer crosstalk-both systemically and within the local tumor environment. [5] In this scenario, the effort to develop alternative anticancer strategies from neural mechanisms is already underway.Cancer pain is one of the most specific embodiments of nerve-tumor interaction. Just like "sensors" embedded in a tumor, pain is the first indication of tumor presence. Nevertheless, as tumor progression, sensory nerves become reorganized, and the pain always rapidly upgrades to severe or chronic pain, which can seriously reduce the quality of patient life. [6] Bone cancer pain induced by bone sarcomas or malignant tumors that spread to the bone is the most severe and common source of pain due to the high incidence rate of skeletal metastases in advanced carcinoma. [7] The nerve-cancer crosstalk via direct chemical signaling (typical H + ) plays a vital role in the formation and progression of bone cancer pain. Because the bone tumor can activate the nuclear factor k-B receptor of osteoclasts to secrete excessive protons, that will stimulate these The tumor microenvironment is a complex milieu where neurons constitute an important non-neoplastic cell type. From "cancer neuroscience," the crosstalk between tumors and neurons favors the rapid growth of both, making the cancer-nerve interaction a reciprocally beneficial process. Thus, cancer-nerve crosstalk may provide new targets for therapeutic intervention against cancer and cancer-related symptoms. We proposed a nerve-cancer crosstalk blocking strategy for metastatic bone cancer pain treatment, achieved by Mg/Al layered-double-hydroxide nanoshells (Mg/Al-LDH) with AZ-23 loaded inside and alendronate decorated outside. The paincausing H + is rapidly eliminated by the LDH, with n...